Publications

[30] [New] Analytical Performance Evaluation of Goldstream Fungus (1-3)-β-D Glucan

[29] Evaluation of a Cryptococcus capsular polysaccharide detection FungiXpert LFA for the rapid diagnosis of Cryptococcosis

[28] The Diagnostic Value of Fully Automatic Instrument for (1-3) -β-d-glucan Test in Patients with Tumour

[27] Clinical Performance Evaluation of a Novel Monotest Glactomannan Detection in the Diagnosis of Invasive Aspergillosis

[26] Research on the Diagnostic Performance of Several Different Galactomannan Methodologies for Invasive Aspergillosis

[25] Lateral Flow Analysis Combinaed with Immunochromatofraphy Analyzer for GM Quantative Detection

[24] Comparison of diferent microbiological procedures for the diagnosis of Pneumocystis jirovecii pneumonia on bronchoalveolar-lavage fuid

[23] Neglecting Genetic Diversity Hinders Timely Diagnosis of Cryptococcus Infec(2)

[22] Evaluation of Carbapenem-Resistant K.N.I.V.O. Detection K-Set for the rapid detection of carbapenemases among carbapenem-resistant gram-negative bacilli

[21] The significance of combination detection of Candida mannan and antibody lateral flow assay for invasive candidiasis diagnosis

[20] The significance of combination detection of Aspergillus antigen and antibody lateral flow assay for invasive pulmonary aspergillosis diagnosis

[19] Novel Diagnostic Method for Fungal Infection — (1,3)-β-D-Glucan Chemiluminescence Immunoassay

[18] Full-Automatic Chemiluminescence Immunoassay System for Aspergillus Galactomannan Detection

[17] Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis systematic review and meta-analysis

[15] Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients

[14] The serum glucan level and pathological changes of antifungal treatment for lower respiratory tract infection of Candida albicans

[13] Evaluation of a Novel Plasma (1,3)-β-d-Glucan Detection Assay for Diagnosis of Candidemia in Pediatric Patients

[12] Platelet Parameters and (1, 3)-β-D-Glucan as a Diagnostic and Prognostic Marker of Invasive Fungal Disease in Preterm Infants

[11] The Screening Performance of Serum 1,3-Beta-D-Glucan in Patients with Invasive Fungal Diseases A Meta-Analysis of Prospective Cohort Studies

[10] Serum Levels of Lipopolysaccharide and 1,3-β-D-Glucan Refer to the Severity in Patients with Crohn’s Disease

[9] Emergence of TR46 Y121F T289A in an Aspergillus fumigatus Isolate from a Chinese Patient

[8] tatistical assessment of Tachypleus amoebocyte lysate for early diagnosis of invasive fungal disease at an ICU in China

[6] Diagnostic Performance of the (1–3)-β-D-Glucan Assay in Pneumocystitis jirovecii, Invasive Aspergillosis, Mucormycosis, Tuberculosis and Healthy Volunteers

[5] Diagnostic performance of the (1–3)-β-Dglucan assay in patients with Pneumocystis

[4] VALUTAZIONE DI UN NUOVO TEST GOLDSTREAM FUNGUS (1,3)-ß-D-Glucano PER LA DIAGNOSTICA DELLE INFEZIONI FUNGINE INVASIVE

[3] VALUTAZIONE DI DUE METODICHE PER IL DOSAGGIO SIERICO DEL 1,3-β-D-GLUCANO IN PAZIENTI A RISCHIO DI INFEZIONI FUNGINE INVASIVE

[2] Evaluation of CrAg lateral flow immunoassay for diagnosis of cryptococcal meningitis patients

[1] Prognostic values of serum galactomannan and (1-3)-beta-D-glucan in hospitalised patients analysis of initial and follow-up results